Senior insider sale
EVP & Chief Financial Officer at ASCENDIS PHARMA A/S — senior position signals high conviction
$2.40M
10K shares
What this filing means
SMITH SCOTT THOMAS plans to sell 10K shares of ASCENDIS PHARMA A/S valued at approximately $2.40M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2026ACC: 0001964306-26-000150
Officer· EVP & Chief Financial Officer
Since Mar 2026
10K
Shares to sell
$2.40M
Approx. market value
10K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Warrant exercise
Cash
3/5/2026
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/5/2026 | Warrant exercise Cash | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10K
Market value
$2.40M
3/5/2026
Total
Units
10K
Value
$2.40M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/5/2026 | 10K | $2.40M | NASDAQ | Planned |
| Total | 10K | $2.40M | ||